Because the AAOS
depends upon voluntary service by Fellows and members to achieve its goals, its disclosure
policy must be realistic and workable. The
actions of Fellows or members in shaping AAOS policy must be as free of outside influence
as possible and be dictated by altruistic principles.
It is recognized that in practicing orthopaedic surgery, Fellows and members may
have other personal and professional interests or commitments, some of which may have the
potential to create conflicts with the best interests of AAOS. AAOS does not view the existence of these
interests or commitments as necessarily implying bias or decreasing the value of
participation in organization activities.
DUTY TO DISCLOSE
Each Fellow or
member has the obligation to disclose all potentially conflicting interests which he or
she identifies during service in an AAOS leadership position or as a member of an AAOS
committee or task force. Fellows or members
must disclose those activities or relationships that are pertinent to the subject matter
of the AAOS activity in which they are involved.
PURPOSE OF DISCLOSURE
The Fellow or
member shall make a disclosure of all potentially conflicting interests at a meeting of
the AAOS committee or task force on which he or she serves in order to avoid
misunderstanding or misrepresentation of his or her motives or interests relative to
participation in a matter before that committee or task force.
WHAT SHOULD BE
DISCLOSED?
Disclosure of
possibly conflicting material interests or commitments include, but are not limited to an
individual's (or a member of his or her immediate family's):
·
Membership on the Board of Directors, officership, editorial position, or
status as a paid employee or paid or non-paid
consultant in any orthopaedic health care-related organization;
·
Personal holdings in
any commercial entity which provides products or services related to the subject matter
under discussion by his or her AAOS committee or task force;
·
Receipt of
significant support* from commercial or other sources related to a subject or product
under consideration by the body of the AAOS on which the Fellow or member serves; or
·
Receipt of
significant support* from commercial or other sources related to a subject or product
presented at an AAOS activity by the Fellow or member, or his/her representative.
These
interests or commitments are listed for illustrative purposes only.
Every
Fellow and member is reminded that full disclosure must be made of any potential conflict
of interest when a matter involving that interest is discussed. This will allow other AAOS Fellows or members to
make an impartial and objective evaluation of the discussion.
ANNUAL STATEMENTS
AND REGULAR UPDATES
The members of the Board of Directors, the
Councils, and AAOS committees and task forces, along with the staff liaison to each
committee or task force and the senior management employees of the Academy, shall discuss
and sign the attached Covenant to Disclose at each group's initial meeting after the
Annual Meeting of the American Academy of Orthopaedic Surgeons (or as soon as practical
thereafter). Each member of the group shall
read and sign the Covenant to Disclose Statement. Once
signed, the staff liaison to the committee or task force shall submit the original
Covenant to Disclose Statement to Meredith London, the Executive Assistant to the
Executive Vice-President. It shall be
retained for at least one year.
In
addition, at each meeting of the Board of
Directors, the Councils and AAOS committees and task forces after the initial meeting of
the year, Fellows and members will be asked to consider their activities and to note to
the group whether there are any additional activities that should be disclosed. This follow-up discussion should be reflected in
the minutes of the group.
A failure to comply with this disclosure policy shall be considered cause for
replacement or removal from office or appointment.
DISCLOSURE BY PARTICIPANTS IN EDUCATIONAL PROGRAMS
All
participants in Academy-sponsored educational activities shall disclose whether they,
their co-authors or the departments with which they are affiliated received something of
value* from a commercial or other party related directly, or indirectly, to the subject of
their participation or presentation. This
mandatory disclosure will involve participants in all aspects of the Annual Meeting,
including scientific papers, symposia, instructional courses, scientific and poster
exhibits, as well as other Academy continuing medical education courses.
Disclosure
shall be in the form and content prescribed by the Board of Directors and shall occur when
applying for, or when requested to participate in, a particular educational activity or
presentation. Failure to comply with this
disclosure requirement will result in the Academy identifying a replacement for the
planned participation.
*Any item, payment or
service valued in excess of $500.
1/99